Evidence map›Paper›PMID 30845708›Full record

ArticleAntibiotics (Basel, Switzerland)2019

Characterization and Antimicrobial Activity of Amphiphilic Peptide AP3 and Derivative Sequences.

Christina L Chrom, Lindsay M Renn, Gregory A Caputo

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Membrane Pore Formation by Peptides Studied by Fluorescence Techniques.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. HAZ, a novel peptide with broad-spectrum antibacterial activity.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Activity and characterization of a pH-sensitive antimicrobial peptide.Biochimica et biophysica acta. Biomembranes · 2019
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christina L ChromDepartment of Chemistry and Biochemistry, Rowan University, Glassboro, NJ 08028, USA. chromc95@rowan.edu.
Lindsay M RennDepartment of Chemistry and Biochemistry, Rowan University, Glassboro, NJ 08028, USA. rennl28@rowan.edu.
Gregory A CaputoDepartment of Chemistry and Biochemistry, Rowan University, Glassboro, NJ 08028, USA. caputo@rowan.edu.ORCID 0000-0002-4510-2815
Rowan University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The continued emergence of new antibiotic resistant bacterial strains has resulted in great interest in the development of new antimicrobial treatments. Antimicrobial peptides (AMPs) are one of many potential classes of molecules to help meet this emerging need. AMPs are naturally derived sequences, which act as part of the innate immune system of organisms ranging from insects through humans. We investigated the antimicrobial peptide AP3, which is originally isolated from the winter flounder

Indexed as

antimicrobial peptidesfluorescence spectroscopymembrane permeabilizationpore-forming peptides

Identifiers

PMID30845708
PMCPMC6466588
OpenAlexW2919524056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.